Recent research progress in this area has been fueled by evidence showing that human cancer development is linked to mutations in genes encoding enzymes in the TCA cycle, such as isocitrate dehydrogenase-1 (IDH1) and -2 (IDH2) in glioblastoma and AML (230–232), as well as in fumarate hydratase (FH) and succinate dehydrogenase (SDH) in other rarer malignancies (6). The gene discussed is FH; the disease is glioblastoma.